The Effects of Chromium Picolinate and Chromium Histidinate Administration on NF-κB and Nrf2/HO-1 Pathway in the Brain of Diabetic Rats
- 13 July 2012
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 150 (1-3) , 291-296
Abstract
The objective of this experiment was to investigate the effects of supplemental chromium picolinate (CrPic) and chromium histidinate (CrHis) on nuclear factor-kappa B (NF-κB p65) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway in diabetic rat brain. Nondiabetic (n = 45) and diabetic (n = 45) male Wistar rats were either not supplemented or supplemented with CrPic or CrHis via drinking water to consume 8 μg elemental chromium (Cr) per day for 12 weeks. Diabetes was induced by streptozotocin injection (40 mg/kg i.p., for 2 weeks) and maintained by high-fat feeding (40 %). Diabetes was associated with increases in cerebral NF-κB and 4-hydroxynonenal (4-HNE) protein adducts and decreased in cerebral nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha (IκBα) and Nrf2 levels. Both Cr chelates were effective to decrease levels of NF-κB and 4-HNE protein adducts and to increase levels of IκBα and Nrf2 in the brain of diabetic rats. However, responses of these increases and decreases were more notable when Cr was supplemented as CrHis than as CrPic. In conclusion, Cr may play a protective role in cerebral antioxidant defense system in diabetic subjects via the Nrf2 pathway by reducing inflammation through NF-κB p65 inhibition. Histidinate form of Cr was superior to picolinate form of Cr in reducing NF-κB expression and increasing Nrf2 expression in the brain of diabetic rats.Keywords
This publication has 34 references indexed in Scilit:
- Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: Old perspective with a new angleBiochemical and Biophysical Research Communications, 2011
- JSH‐23 targets nuclear factor‐kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defenceDiabetes, Obesity and Metabolism, 2011
- Chromium is not an essential trace element for mammals: effects of a “low-chromium” dietJBIC Journal of Biological Inorganic Chemistry, 2010
- A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disordersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
- Chromium: celebrating 50 years as an essential element?Dalton Transactions, 2010
- The Antioxidant Response as a Drug Target in Diabetic NeuropathyCurrent Drug Targets, 2008
- Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B PathwayCurrent Drug Targets, 2008
- Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury–induced Neuropathic Pain in the RatMolecular Therapy, 2007
- New insights into the pathogenesis of diabetic neuropathyCurrent Opinion in Neurology, 1999
- Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatmentBrain Research, 1998